Cargando...
Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible
Recent studies have demonstrated that erythropoietin (EPO) treatment in mice results in trabecular bone loss. Here, we investigated the dose-response relationship between EPO, hemoglobin (Hgb) and bone loss and examined the reversibility of EPO-induced damage. Increasing doses of EPO over two weeks...
Guardado en:
| Publicado en: | Int J Mol Sci |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7312352/ https://ncbi.nlm.nih.gov/pubmed/32471308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21113817 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|